We are live on ! Find out more
NI

Nextech Invest Portfolio holdings

AUM $1.42B
1-Year Est. Return 304.47%
This Fund
S&P 500
This Quarter Est. Return
-5.76%
1 Year Est. Return
+304.47%
3 Year Est. Return
+631.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$251M
AUM Growth
-$58.3M
Cap. Flow
-$2.71M
Cap. Flow %
-1.08%
Top 10 Hldgs %
94.15%
Holding
14
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$2.71M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$38.6B
$99.8M 39.7%
4,189,529
– –
EQRX
2
DELISTED
EQRx, Inc. Common Stock
EQRX
$32.2M 12.82%
13,104,424
– –
TYRA icon
3
Tyra Biosciences
TYRA
$1.84B
$19.1M 7.62%
2,518,582
– –
SPRY icon
4
ARS Pharmaceuticals
SPRY
$574M
$16.3M 6.48%
1,910,029
– –
KNTE
5
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$14.2M 5.65%
2,329,480
-332,408
-12% -$2.71M
CGEM icon
6
Cullinan Oncology
CGEM
$1.04B
$12.9M 5.13%
1,221,145
– –
PMVP icon
7
PMV Pharmaceuticals
PMVP
$57.1M
$12.1M 4.8%
1,385,807
– –
MRTX
8
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$12M 4.76%
263,914
– –
ARVN icon
9
Arvinas
ARVN
$535M
$9.83M 3.91%
287,251
– –
BPMC
10
DELISTED
Blueprint Medicines
BPMC
$8.25M 3.28%
188,228
– –
RLAY icon
11
Relay Therapeutics
RLAY
$4.01B
$7.1M 2.83%
475,485
– –
THRX
12
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$3.04M 1.21%
611,310
– –
KRON
13
DELISTED
Kronos Bio
KRON
$2.35M 0.94%
1,451,537
– –
CCCC icon
14
C4 Therapeutics
CCCC
$391M
$2.22M 0.88%
375,857
– –

Similar funds

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Nextech Invest's Q4 2022 Portfolio in Review

As of Q4 2022, Nextech Invest held 14 positions worth $251M, down 19% from $310M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 0%. Nextech Invest opened no new positions and made no exits, leaving the 14-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Nextech Invest's biggest Q4 2022 reduction was Kinnate Biopharma Inc. Common Stock, cutting an estimated $2.71M.
  • Nextech Invest's ten largest holdings make up 94% of its $251M portfolio in Q4 2022.
  • Nextech Invest opened 0 new positions and closed 0 in Q4 2022.
  • Nextech Invest's portfolio value fell 19% quarter-over-quarter to $251M.

Based on Nextech Invest's 13F filing for Q4 2022, filed 14 Feb 2023.